PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
- Vosoughi S et al. The spread of true and false news online. Science 2018;359:1146-1151. doi: 10.1126/science.aap9559.
- Solis Arce JS et al. COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries. Nature Medicine 2021;27:1385-1394. doi: 10.1038/s41591-021-01454-y.
- Metlay JP et al. Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients. J Gen Intern Med 2002;17(2):87-94. doi: 10.1046/j.1525-1497.2002.10711.x.
- Wang et al. Development of Multifaceted Antimicrobial Stewardship Curriculum for Undergraduate Medical Education: The Antibiotic Stewardship, Safety, utilization, Resistance, and Evaluation (ASSURE) Elective. _Open Forum Infect Dis _2021;8(6): ofab231. https://doi.org/10.1093/ofid/ofab231.
- Charani E et al. Understanding the Determinants of Antimicrobial Prescribing Within Hospitals: The Role of “Prescribing Etiquette.” Clin Infect Dis 2013;57(2):188-196. doi: 10.1093/cid/cit212.
- Lines TH et al. Driving antimicrobial use improvement: attitudes of providers of adult hospital care on optimal attribution and feedback. Infect Control Hosp Epidemiol 2018;39(8):983-985. doi: 10.1017/ice.2018.113.
- Teshome BF et al. Duration of Exposure to Antipseudomonal B-Lactam Antibiotics in the Critically Ill and Development of New Resistance. Pharmacotherapy 2019;39(3):261-270. doi: 10.1002/phar.2201.
- Teshome BF et al. Evaluation of a ceiling effect on the association of new resistance development to antipseudomonal beta-lactam exposure in the critically ill. Infect Control Hosp Epidemiol 2020;41(4):484-485.
- Leone M et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med 2014;40: 1399-1408. doi: 10.1007/s00134-014-3411-8.
- Stevens V et al. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 2011;53(1):42-48. doi: 10.1093/cid/cir301.
- Bhalodi A et al. Impact of antimicrobial therapy on the gut microbiome. J Antimicrob Chemother 2019;74(Suppl 1):i6-i15. doi: 10.1093/jac/dky530.
Timothy Gauthier, PharmD, BCPS, BCIDP
Dr. Timothy Gauthier obtained a Doctor of Pharmacy degree from NorthEastern University School of Pharmacy, then completed 2 years of pharmacy residency training at Jackson Memorial Hospital in Miami, FL to specialize in Infectious Diseases. He spent his first decade as an ID pharmacist working as faculty at Nova SouthEastern University in Fort Lauderdale and for the Miami VA health care system. He is currently the antimicrobial stewardship clinical program manager and PGY2 ID pharmacy residency program director for Baptist Health South Florida. He is an active member of SIDP and the ACCP ID PRN. He is best known in the profession of pharmacy for his social media preference (@IDstewardship) He is also editor in chief of www.IDstewardship.com and learnantibiotics.com.
Jillian Hayes, PharmD, BCIDP
Dr. Jillian Hayes is an Infectious Diseases Clinical Pharmacy Specialist at AdventHealth Orlando. She obtained her Doctor of Pharmacy degree from the University of South Carolina and then completed her PGY1 and PGY2 ID pharmacy residency at Vanderbilt University Medical Center in Nashville Tennessee. She is an active member of SIDP and the ACCP ID PRN. She is also the 2022 vice chair of the SIDP publications and podcasts committee. Her interests include antimicrobial stewardship in transitions of care, resident wellness and mentoring, and preventing the prescribing of cefdinir whenever possible.
